CD40LG as a Biomarker in Rheumatoid Arthritis: Links to Bone Destruction and Interstitial Lung Disease ‐ A Bioinformatic Analysis With Clinical Validation
CD40LG is a potential biomarker for RA, especially in patients with ILD or bone damage. Emetine, oligomycin, cromoglicic acid, sulfinpyrazone, buspirone, and chlorogenic acid are potential therapeutic agents for RA treatments.
Authors
- Juan Jiao (ORCID: https://orcid.org/0000-0002-4370-5137)
- Chuanhui Yao
- Xiaopo Tang (ORCID: https://orcid.org/0000-0002-0569-4502)
- Quan Jiang (ORCID: https://orcid.org/0000-0002-3031-7848)
- Xun Gong (ORCID: https://orcid.org/0000-0002-3377-0373)
- Congmin Xia
- Yuchen Yang (ORCID: https://orcid.org/0000-0001-7127-1930)
- Hui Xu (ORCID: https://orcid.org/0000-0002-7596-8011)
- Dan Dou
- Xieli Ma
- Qiuwei Peng
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guang’anmen Hospital (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/hsr2.71318
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Academy of Traditional Chinese Medicine